Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc.（FRX.TO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
frx.to · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $12.72
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $13.25 | ↑ 4.20% |
1-day model range: $13.07–$13.44. Peak: $13.44 (+4.20%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $12 | -9.0% |
| 2028 | $11 | -13.6% |
| 2029 | $11 | -15.9% |
| 2030 | $11 | -17.2% |
| 2031 | — | -17.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FRX.TO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-16 | Wedbush | Maintains | Outperform→Outperform |
| 2025-08-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-15 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-05-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-14 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-14 | Craig-Hallum | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Fennec Pharmaceuticals Inc. (FRX.TO) stock. Of the recent 32 rating actions, 1 were upgrades and 0 were downgrades. 7 analysts currently cover FRX.TO.
分析师推荐趋势
FRX.TO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$68M
↓ 51.1% YoY
Revenue Next Year
$102M
↑ 49.8% YoY
EPS This Year
$0.26
EPS Next Year
$1.01
↑ 284.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast FRX.TO EPS of $0.26 for the current fiscal year, based on estimates from 6 analysts. The FRX.TO revenue forecast is $68M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
FRX.TO 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。FRX.TO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
FRX.TO 的短期预测（明日）为 $13.25（+4.20%）。 FRX.TO 对 2027 年的股价预测均值为 $12。 FRX.TO 对 2030 年的预测区间为 $9–$12。
Fennec Pharmaceuticals Inc. 在 TSX 上市，代码 FRX.TO。FRX.TO 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
FRX.TO 预测 · 8 个问题根据 7 位华尔街分析师，FRX.TO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $12.72，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.